Related Experiment Video
Updated: Oct 27, 2025

Author Spotlight: Flow Cytometric Determination of Pyroptosis in Avian Cells
Published on: May 31, 2024
Pyroptosis in Cancer: Friend or Foe?
Xiuxia Lu1, Tianhui Guo1, Xing Zhang1
1Melanoma and Sarcoma Medical Oncology Unit, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China.
Pyroptosis, an inflammatory cell death, is triggered by gasdermin proteins (GSDMs). Its precise role in cancer immunity, especially after treatments like chemotherapy, requires further investigation.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Pyroptosis is a pro-inflammatory programmed cell death pathway.
- It is executed by gasdermin proteins (GSDMs) that form membrane pores.
- The role of pyroptosis in cancer and its impact on anti-tumor immunity is complex and debated.
Purpose of the Study:
- To review the discovery and mechanisms of pyroptosis.
- To discuss the involvement of pyroptosis in inflammatory diseases.
- To critically evaluate the role of pyroptosis in cancer immunity, particularly in response to therapies.
Main Methods:
- Literature review of pyroptosis mechanisms and functions.
- Analysis of studies investigating pyroptosis in cancer.
- Synthesis of findings on pyroptosis induction by various stimuli and therapies.
Main Results:
- Gasdermin N-termini oligomerize to form pores, leading to pyroptosis.
- Pyroptosis can be triggered by pathogen-associated molecular patterns (PAMPs), damage-associated molecular patterns (DAMPs), and chemotherapeutic drugs.
- Conflicting evidence exists regarding whether pyroptosis benefits or harms anti-tumor immunity.
Conclusions:
- Pyroptosis is a key inflammatory cell death pathway with implications beyond inflammatory diseases.
- Understanding pyroptosis's dual role in cancer is crucial for developing effective anti-cancer strategies.
- Further research is needed to clarify pyroptosis's impact on tumor immunity and therapeutic outcomes.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

